Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The Society for Clinical Research Sites (SCRS) is proud to announce the launch of the Global Impact Partnership (GIP) Program. In just over a month, twelve organizations have joined SCRS’ commitment to research site’s success. SCRS Global Impact ...
read more
Wednesday, February 25, 2015
By joining the InCrowd information exchange, Skipta members benefit from personalized access to contribute insights and conveniently complete short, focused research surveys.
read more
Monday, February 11, 2019
Sharp has announced a $650,000 investment into enhancing its Interactive Response Technology (IRT) solution.
read more
SGS has received approval from FAMHP and has initiated the first site to begin a new clinical trial of a potential treatment for patients with COVID-19 related respiratory failure.
read more
SGS announced the company will implement the Veeva Vault CTMS across its network of clinical operations sites for the management of its global clinical study services.
read more
Friday, February 15, 2013
SGS expands its Clinical Pharmacology Unit in Antwerp, Belgium with a Viral Challenge Testing facility including a 12-bed, Biosafety Level 2-Q compliant, quarantine facility.
read more
Friday, September 04, 2020
SGS has announced the enrollment of the first patient into a new clinical trial designed to examine the safety, tolerability, and efficacy of a potential drug candidate for people suffering with COVID-19 related respiratory failure.
read more
Seven Bridges has been selected by the PanCAN to build a customized, integrated health data platform to accelerate pancreatic cancer research.
read more
The Oracle Health Sciences' Clinical One platform has been selected by Servier to make its vision of a next-generation clinical trial management environment a reality. To start and manage clinical trials is a lengthy and regulated process that ...
read more
Thursday, November 08, 2012
SCYNEXIS, Inc. today announced that the results of a Phase 2a study of lead candidate SCY-635 for the treatment of the hepatitis C virus (HCV) will be the subject of an oral presentation at the 63rd Annual Meeting of the American Association for the ...
read more
SCYNEXIS, Inc. announced today that Merck, known as MSD outside the United States and Canada, has decided to return to SCYNEXIS all development and commercialization rights for the novel antifungal compound, MK-3118, an oral glucan synthase inhibitor...
read more
SCYNEXIS, Inc. announced today that Immune Design Corp. has selected SCYNEXIS as its chemical development and cGMP production partner for manufacture of Glucopyranosyl Lipid A (GLA).
read more
Wednesday, April 03, 2013
Sciformix Corporation, a world leading Scientific Process Organization (SPO), has announced its premium sponsorship of the 5th annual World Drug Safety Congress, taking place from April 24 - 25, 2013 at the Revere Hotel Boston Common, Boston, USA. ...
read more
Thursday, February 27, 2014
Sciformix Corporation, a leading Scientific Process Organization (SPO), has announced its presentation of novel practices in labeling management at the 2nd Annual Pharma Labeling Compliance Conference taking place March 19th-20th in Boston, MA. Bindu...
read more
ScienceMedia announced their partnership with Apex Mobile Clinical Research (AMCR), a provider of decentralized clinical trial solutions and services to underserved communities. AMCR will be using ScienceMedia's protocol compliance management ...
read more